INS and type 2 diabetes mellitus: These local inflammatory processes, coupled with glucolipotoxicity, result in the accelerated loss of β-cell mass via cell apoptosis or death and severely impair the insulin-producing capabilities of the remaining β-cells in T2DM patients as well as in rodent models.